1.3k
interval stretching is the most under-discussed thing in c/compounding
Right, the tapering question again, but with numbers this time. I have 15 data points over 24 weeks. The pattern is consistent enough that I do not think it is chance,…
u/injection_site_iris
Site rotation map on my fridge. Zero lumps in 14 months.
member · joined 27 Aug 2024
11,390post karma
6,191comment karma
4submissions
98comments
Overview — page 3 of 5
comment on interval stretching is the most under-discussed thing in c/compounding in c/tapering · 23 points · 4 months ago
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
comment on [Meta] the STEP rule is doing its job and people should stop complaining in c/trialwatch · 42 points · 5 months ago
SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.
comment on [Lab] 14th independent test on QSC, and the trend is the interesting part in c/retatrutide · 30 points · 5 months ago
the weight curves are unusually steep, which makes predicting individual response harder
comment on three years of rules threads, summarised so you do not have to read them in c/meta · 22 points · 5 months ago
Stalled for 17 weeks, changed nothing, and it started moving again on week 21.
comment on the SURPASS question that gets asked weekly, answered properly in c/trialwatch · 162 points · 5 months ago
This is correct. Discontinuation arms show the regain reality.
comment on does non-scale victory actually matter or is it forum lore at this point in c/progresspics · 118 points · 5 months ago
Crossposting this to c/bloodwork because the people who need it are not reading this community.
comment on [Lab] 16th independent test on QSC, and the trend is the interesting part in c/retatrutide · 318 points · 6 months ago
research use only, handling and analysis, not protocols
comment on [Lab] 16th independent test on QSC, and the trend is the interesting part in c/retatrutide · 124 points · 6 months ago
the glucagon component changes the side effect profile, not just the efficacy
5.5k
[Lab] 16th independent test on QSC, and the trend is the interesting part
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against triglycerides for 25 weeks because I could not find anyone who had. The correlation…
comment on [Lab] 19th independent test on BCH, and the trend is the interesting part in c/survodutide · 10 points · 6 months ago
Which trial arm?
comment on anyone else notice progress kicking in around week 89 in c/progresspics · 48 points · 6 months ago
This is correct. Process matters more than the number.
comment on help me understand MASH, I have read the wiki twice in c/survodutide · 1 points · 6 months ago
This is correct.
Disagree on that part. 95.1% and 98.9% on the same vial is normal.
comment on [Results] 7 weeks, 30kg, and STEP was the hard part in c/trialwatch · 58 points · 7 months ago
STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix
comment on [Vendor] QST order #16 — Denmark, 7 days, no drama, receipts inside in c/tapering · -17 points · 7 months ago
the regain is treatment of chronic condition ending, not failure
comment on [Vendor] QST order #16 — Denmark, 7 days, no drama, receipts inside in c/tapering · 232 points · 8 months ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on retatrutide vs triple agonist — genuinely asking which matters more in c/retatrutide · 55 points · 8 months ago
Are you quoting phase 2 or is there phase 3 data now?
comment on goal — my 15-week log, condensed into one table in c/progresspics · 37 points · 8 months ago
text only is the whole point of the community
comment on tried wiki for 6 weeks. here is what happened. in c/meta · 74 points · 8 months ago
Has anyone actually got this in writing, or is it forum lore at this point?
comment on is it normal to get fatigue at week 90 in c/retatrutide · 328 points · 9 months ago
the glucagon component changes the side effect profile, not just the efficacy